6-(5-bromo-1H-indol-3-yl)-1,4,5,6-tetrahydropyrimidin-2-amine;N-[6-(5-bromo-1H-indol-3-yl)-1,4,5,6-tetrahydropyrimidin-2-yl]acetamide;6-(5-bromo-1-methoxyindol-3-yl)-1,4,5,6-tetrahydropyrimidin-2-amine;N-[6-(5-bromo-1-methoxyindol-3-yl)-1,4,5,6-tetrahydropyrimidin-2-yl]acetamide;6-(5,6-dibromo-1-methoxyindol-3-yl)-1,4,5,6-tetrahydropyrimidin-2-amine;N-[6-(5,6-dibromo-1-methoxyindol-3-yl)-1,4,5,6-tetrahydropyrimidin-2-yl]acetamide

C82H90Br8N24O7 — CID 159953092

About 6-(5-bromo-1H-indol-3-yl)-1,4,5,6-tetrahydropyrimidin-2-amine;N-[6-(5-bromo-1H-indol-3-yl)-1,4,5,6-tetrahydropyrimidin-2-yl]acetamide;6-(5-bromo-1-methoxyindol-3-yl)-1,4,5,6-tetrahydropyrimidin-2-amine;N-[6-(5-bromo-1-methoxyindol-3-yl)-1,4,5,6-tetrahydropyrimidin-2-yl]acetamide;6-(5,6-dibromo-1-methoxyindol-3-yl)-1,4,5,6-tetrahydropyrimidin-2-amine;N-[6-(5,6-dibromo-1-methoxyindol-3-yl)-1,4,5,6-tetrahydropyrimidin-2-yl]acetamide

6-(5-bromo-1H-indol-3-yl)-1,4,5,6-tetrahydropyrimidin-2-amine;N-[6-(5-bromo-1H-indol-3-yl)-1,4,5,6-tetrahydropyrimidin-2-yl]acetamide;6-(5-bromo-1-methoxyindol-3-yl)-1,4,5,6-tetrahydropyrimidin-2-amine;N-[6-(5-bromo-1-methoxyindol-3-yl)-1,4,5,6-tetrahydropyrimidin-2-yl]acetamide;6-(5,6-dibromo-1-methoxyindol-3-yl)-1,4,5,6-tetrahydropyrimidin-2-amine;N-[6-(5,6-dibromo-1-methoxyindol-3-yl)-1,4,5,6-tetrahydropyrimidin-2-yl]acetamide (PubChem CID 159953092) has the molecular formula C82H90Br8N24O7 and a molecular weight of 2163.01 g/mol. Its IUPAC name is 6-(5-bromo-1H-indol-3-yl)-1,4,5,6-tetrahydropyrimidin-2-amine;N-[6-(5-bromo-1H-indol-3-yl)-1,4,5,6-tetrahydropyrimidin-2-yl]acetamide;6-(5-bromo-1-methoxyindol-3-yl)-1,4,5,6-tetrahydropyrimidin-2-amine;N-[6-(5-bromo-1-methoxyindol-3-yl)-1,4,5,6-tetrahydropyrimidin-2-yl]acetamide;6-(5,6-dibromo-1-methoxyindol-3-yl)-1,4,5,6-tetrahydropyrimidin-2-amine;N-[6-(5,6-dibromo-1-methoxyindol-3-yl)-1,4,5,6-tetrahydropyrimidin-2-yl]acetamide.

Molecular Properties

• Compound Name: 6-(5-bromo-1H-indol-3-yl)-1,4,5,6-tetrahydropyrimidin-2-amine;N-[6-(5-bromo-1H-indol-3-yl)-1,4,5,6-tetrahydropyrimidin-2-yl]acetamide;6-(5-bromo-1-methoxyindol-3-yl)-1,4,5,6-tetrahydropyrimidin-2-amine;N-[6-(5-bromo-1-methoxyindol-3-yl)-1,4,5,6-tetrahydropyrimidin-2-yl]acetamide;6-(5,6-dibromo-1-methoxyindol-3-yl)-1,4,5,6-tetrahydropyrimidin-2-amine;N-[6-(5,6-dibromo-1-methoxyindol-3-yl)-1,4,5,6-tetrahydropyrimidin-2-yl]acetamide
• PubChem CID: 159953092
• Molecular Formula: C82H90Br8N24O7
• Molecular Weight: 2163.01 g/mol
• Exact Mass: 2154.09
• IUPAC Name: 6-(5-bromo-1H-indol-3-yl)-1,4,5,6-tetrahydropyrimidin-2-amine;N-[6-(5-bromo-1H-indol-3-yl)-1,4,5,6-tetrahydropyrimidin-2-yl]acetamide;6-(5-bromo-1-methoxyindol-3-yl)-1,4,5,6-tetrahydropyrimidin-2-amine;N-[6-(5-bromo-1-methoxyindol-3-yl)-1,4,5,6-tetrahydropyrimidin-2-yl]acetamide;6-(5,6-dibromo-1-methoxyindol-3-yl)-1,4,5,6-tetrahydropyrimidin-2-amine;N-[6-(5,6-dibromo-1-methoxyindol-3-yl)-1,4,5,6-tetrahydropyrimidin-2-yl]acetamide
• SMILES: CC(=O)NC1=NCCC(c2c[nH]c3ccc(Br)cc23)N1.COn1cc(C2CCN=C(N)N2)c2cc(Br)c(Br)cc21.COn1cc(C2CCN=C(N)N2)c2cc(Br)ccc21.COn1cc(C2CCN=C(NC(C)=O)N2)c2cc(Br)c(Br)cc21.COn1cc(C2CCN=C(NC(C)=O)N2)c2cc(Br)ccc21.NC1=NCCC(c2c[nH]c3ccc(Br)cc23)N1
• InChI: InChI=1S/C15H16Br2N4O2.C15H17BrN4O2.C14H15BrN4O.C13H14Br2N4O.C13H15BrN4O.C12H13BrN4/c1-8(22)19-15-18-4-3-13(20-15)10-7-21(23-2)14-6-12(17)11(16)5-9(10)14;1-9(21)18-15-17-6-5-13(19-15)12-8-20(22-2)14-4-3-10(16)7-11(12)14;1-8(20)18-14-16-5-4-13(19-14)11-7-17-12-3-2-9(15)6-10(11)12;1-20-19-6-8(11-2-3-17-13(16)18-11)7-4-9(14)10(15)5-12(7)19;1-19-18-7-10(11-4-5-16-13(15)17-11)9-6-8(14)2-3-12(9)18;13-7-1-2-10-8(5-7)9(6-16-10)11-3-4-15-12(14)17-11/h5-7,13H,3-4H2,1-2H3,(H2,18,19,20,22);3-4,7-8,13H,5-6H2,1-2H3,(H2,17,18,19,21);2-3,6-7,13,17H,4-5H2,1H3,(H2,16,18,19,20);4-6,11H,2-3H2,1H3,(H3,16,17,18);2-3,6-7,11H,4-5H2,1H3,(H3,15,16,17);1-2,5-6,11,16H,3-4H2,(H3,14,15,17)
• InChIKey: OCJCQGZLAOOGTI-UHFFFAOYSA-N
• XLogP: 13.86
• TPSA: 399.92 Ų
• H-Bond Donors: 14
• H-Bond Acceptors: 26
• Rotatable Bonds: 10
• Heavy Atoms: 121
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	2163.01
LogP ≤ 5	13.86
H-Bond Donors ≤ 5	14
H-Bond Acceptors ≤ 10	26

Frequently Asked Questions

What is the IUPAC name of 6-(5-bromo-1H-indol-3-yl)-1,4,5,6-tetrahydropyrimidin-2-amine;N-[6-(5-bromo-1H-indol-3-yl)-1,4,5,6-tetrahydropyrimidin-2-yl]acetamide;6-(5-bromo-1-methoxyindol-3-yl)-1,4,5,6-tetrahydropyrimidin-2-amine;N-[6-(5-bromo-1-methoxyindol-3-yl)-1,4,5,6-tetrahydropyrimidin-2-yl]acetamide;6-(5,6-dibromo-1-methoxyindol-3-yl)-1,4,5,6-tetrahydropyrimidin-2-amine;N-[6-(5,6-dibromo-1-methoxyindol-3-yl)-1,4,5,6-tetrahydropyrimidin-2-yl]acetamide?

The IUPAC name of 6-(5-bromo-1H-indol-3-yl)-1,4,5,6-tetrahydropyrimidin-2-amine;N-[6-(5-bromo-1H-indol-3-yl)-1,4,5,6-tetrahydropyrimidin-2-yl]acetamide;6-(5-bromo-1-methoxyindol-3-yl)-1,4,5,6-tetrahydropyrimidin-2-amine;N-[6-(5-bromo-1-methoxyindol-3-yl)-1,4,5,6-tetrahydropyrimidin-2-yl]acetamide;6-(5,6-dibromo-1-methoxyindol-3-yl)-1,4,5,6-tetrahydropyrimidin-2-amine;N-[6-(5,6-dibromo-1-methoxyindol-3-yl)-1,4,5,6-tetrahydropyrimidin-2-yl]acetamide (CID 159953092) is 6-(5-bromo-1H-indol-3-yl)-1,4,5,6-tetrahydropyrimidin-2-amine;N-[6-(5-bromo-1H-indol-3-yl)-1,4,5,6-tetrahydropyrimidin-2-yl]acetamide;6-(5-bromo-1-methoxyindol-3-yl)-1,4,5,6-tetrahydropyrimidin-2-amine;N-[6-(5-bromo-1-methoxyindol-3-yl)-1,4,5,6-tetrahydropyrimidin-2-yl]acetamide;6-(5,6-dibromo-1-methoxyindol-3-yl)-1,4,5,6-tetrahydropyrimidin-2-amine;N-[6-(5,6-dibromo-1-methoxyindol-3-yl)-1,4,5,6-tetrahydropyrimidin-2-yl]acetamide.

What is the SMILES notation for 6-(5-bromo-1H-indol-3-yl)-1,4,5,6-tetrahydropyrimidin-2-amine;N-[6-(5-bromo-1H-indol-3-yl)-1,4,5,6-tetrahydropyrimidin-2-yl]acetamide;6-(5-bromo-1-methoxyindol-3-yl)-1,4,5,6-tetrahydropyrimidin-2-amine;N-[6-(5-bromo-1-methoxyindol-3-yl)-1,4,5,6-tetrahydropyrimidin-2-yl]acetamide;6-(5,6-dibromo-1-methoxyindol-3-yl)-1,4,5,6-tetrahydropyrimidin-2-amine;N-[6-(5,6-dibromo-1-methoxyindol-3-yl)-1,4,5,6-tetrahydropyrimidin-2-yl]acetamide?

The canonical SMILES for 6-(5-bromo-1H-indol-3-yl)-1,4,5,6-tetrahydropyrimidin-2-amine;N-[6-(5-bromo-1H-indol-3-yl)-1,4,5,6-tetrahydropyrimidin-2-yl]acetamide;6-(5-bromo-1-methoxyindol-3-yl)-1,4,5,6-tetrahydropyrimidin-2-amine;N-[6-(5-bromo-1-methoxyindol-3-yl)-1,4,5,6-tetrahydropyrimidin-2-yl]acetamide;6-(5,6-dibromo-1-methoxyindol-3-yl)-1,4,5,6-tetrahydropyrimidin-2-amine;N-[6-(5,6-dibromo-1-methoxyindol-3-yl)-1,4,5,6-tetrahydropyrimidin-2-yl]acetamide is CC(=O)NC1=NCCC(c2c[nH]c3ccc(Br)cc23)N1.COn1cc(C2CCN=C(N)N2)c2cc(Br)c(Br)cc21.COn1cc(C2CCN=C(N)N2)c2cc(Br)ccc21.COn1cc(C2CCN=C(NC(C)=O)N2)c2cc(Br)c(Br)cc21.COn1cc(C2CCN=C(NC(C)=O)N2)c2cc(Br)ccc21.NC1=NCCC(c2c[nH]c3ccc(Br)cc23)N1.

What is the InChIKey of 6-(5-bromo-1H-indol-3-yl)-1,4,5,6-tetrahydropyrimidin-2-amine;N-[6-(5-bromo-1H-indol-3-yl)-1,4,5,6-tetrahydropyrimidin-2-yl]acetamide;6-(5-bromo-1-methoxyindol-3-yl)-1,4,5,6-tetrahydropyrimidin-2-amine;N-[6-(5-bromo-1-methoxyindol-3-yl)-1,4,5,6-tetrahydropyrimidin-2-yl]acetamide;6-(5,6-dibromo-1-methoxyindol-3-yl)-1,4,5,6-tetrahydropyrimidin-2-amine;N-[6-(5,6-dibromo-1-methoxyindol-3-yl)-1,4,5,6-tetrahydropyrimidin-2-yl]acetamide?

The InChIKey is OCJCQGZLAOOGTI-UHFFFAOYSA-N. The full InChI is InChI=1S/C15H16Br2N4O2.C15H17BrN4O2.C14H15BrN4O.C13H14Br2N4O.C13H15BrN4O.C12H13BrN4/c1-8(22)19-15-18-4-3-13(20-15)10-7-21(23-2)14-6-12(17)11(16)5-9(10)14;1-9(21)18-15-17-6-5-13(19-15)12-8-20(22-2)14-4-3-10(16)7-11(12)14;1-8(20)18-14-16-5-4-13(19-14)11-7-17-12-3-2-9(15)6-10(11)12;1-20-19-6-8(11-2-3-17-13(16)18-11)7-4-9(14)10(15)5-12(7)19;1-19-18-7-10(11-4-5-16-13(15)17-11)9-6-8(14)2-3-12(9)18;13-7-1-2-10-8(5-7)9(6-16-10)11-3-4-15-12(14)17-11/h5-7,13H,3-4H2,1-2H3,(H2,18,19,20,22);3-4,7-8,13H,5-6H2,1-2H3,(H2,17,18,19,21);2-3,6-7,13,17H,4-5H2,1H3,(H2,16,18,19,20);4-6,11H,2-3H2,1H3,(H3,16,17,18);2-3,6-7,11H,4-5H2,1H3,(H3,15,16,17);1-2,5-6,11,16H,3-4H2,(H3,14,15,17).

What are the key properties of 6-(5-bromo-1H-indol-3-yl)-1,4,5,6-tetrahydropyrimidin-2-amine;N-[6-(5-bromo-1H-indol-3-yl)-1,4,5,6-tetrahydropyrimidin-2-yl]acetamide;6-(5-bromo-1-methoxyindol-3-yl)-1,4,5,6-tetrahydropyrimidin-2-amine;N-[6-(5-bromo-1-methoxyindol-3-yl)-1,4,5,6-tetrahydropyrimidin-2-yl]acetamide;6-(5,6-dibromo-1-methoxyindol-3-yl)-1,4,5,6-tetrahydropyrimidin-2-amine;N-[6-(5,6-dibromo-1-methoxyindol-3-yl)-1,4,5,6-tetrahydropyrimidin-2-yl]acetamide?

6-(5-bromo-1H-indol-3-yl)-1,4,5,6-tetrahydropyrimidin-2-amine;N-[6-(5-bromo-1H-indol-3-yl)-1,4,5,6-tetrahydropyrimidin-2-yl]acetamide;6-(5-bromo-1-methoxyindol-3-yl)-1,4,5,6-tetrahydropyrimidin-2-amine;N-[6-(5-bromo-1-methoxyindol-3-yl)-1,4,5,6-tetrahydropyrimidin-2-yl]acetamide;6-(5,6-dibromo-1-methoxyindol-3-yl)-1,4,5,6-tetrahydropyrimidin-2-amine;N-[6-(5,6-dibromo-1-methoxyindol-3-yl)-1,4,5,6-tetrahydropyrimidin-2-yl]acetamide has a molecular weight of 2163.01 g/mol, XLogP of 13.86, 10 rotatable bonds, 14 hydrogen bond donors, and 26 hydrogen bond acceptors.

Where does this data come from?

All data for 6-(5-bromo-1H-indol-3-yl)-1,4,5,6-tetrahydropyrimidin-2-amine;N-[6-(5-bromo-1H-indol-3-yl)-1,4,5,6-tetrahydropyrimidin-2-yl]acetamide;6-(5-bromo-1-methoxyindol-3-yl)-1,4,5,6-tetrahydropyrimidin-2-amine;N-[6-(5-bromo-1-methoxyindol-3-yl)-1,4,5,6-tetrahydropyrimidin-2-yl]acetamide;6-(5,6-dibromo-1-methoxyindol-3-yl)-1,4,5,6-tetrahydropyrimidin-2-amine;N-[6-(5,6-dibromo-1-methoxyindol-3-yl)-1,4,5,6-tetrahydropyrimidin-2-yl]acetamide is sourced from PubChem (CID 159953092), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).